Siemens Healthineers · 5 hours ago
Strategy MBA Intern
Siemens Healthineers is a leader in medical technology, dedicated to pioneering breakthroughs in healthcare. They are seeking a Strategy MBA Intern to advance commercial strategies in the Americas through data-driven insights, conducting market analysis, and exploring innovative business opportunities.
Health CareHealth DiagnosticsMedicalMedical Device
Responsibilities
Conducting comprehensive market landscaping to identify competitive dynamics, emerging trends, and whitespace opportunities across key segments
Contributing to strategic analysis in high-priority growth areas for the company, including sustainability
Exploring innovative business and partnership opportunities, as well as evaluating potential strategic investments, to support our strategic objectives
Prepare briefing materials, presentations, and recommendations for leadership discussions
Qualification
Required
Currently enrolled in an MBA degree program
Professional experience in market research, strategy consulting, corporate strategy, business operations or product marketing preferred
Demonstrated ability to collect, analyze and communicate data (presentations, etc.)
Demonstrated ability to be a self-starter and multitask while maintaining attention to detail
Strong project management and communication skills
Proven problem-solving skills. Ability to create a structured approach to problem solving to tackle open-ended situations, and move swiftly from analysis to a recommendation
Proven success in partnering, influencing, and collaborating internally and externally to establish shared vision and delivering results on specific goals
Permanent work authorization in the U.S. is required
Preferred
Professional experience in market research, strategy consulting, corporate strategy, business operations or product marketing preferred
Benefits
Siemens Healthineers offers interns paid time off.
Company
Siemens Healthineers
Siemens Healthineers is a healthcare technology company that provides diagnostic and therapeutic products and services. It is a sub-organization of Siemens.
Funding
Current Stage
Public CompanyTotal Funding
$2.76BKey Investors
Ontario Together Fund
2021-05-25Grant· $2.5M
2021-03-25Post Ipo Equity· $2.76B
2018-03-16IPO
Leadership Team
Recent News
2026-01-21
Company data provided by crunchbase